Fulcrum Therapeutics, Inc, based in Cambridge, MA, is dedicated to modulating gene expression to address the root cause of genetically defined diseases. Specializing in areas of high unmet medical need, the company focuses on improving the lives of patients through innovative therapeutic approaches.
With a pipeline that includes the lead program losmapimod targeting facioscapulohumeral muscular dystrophy (FSHD), Fulcrum Therapeutics is at the forefront of developing treatments for conditions such as sickle cell disease (SCD) and beta-thalassemia. Committed to fostering a culture defined by core values, the company offers opportunities for individuals to join their mission-driven team.
Generated from the website